Astarabine
|
A671343-5mg
|
≥95% |
2098942-53-9 |
5mg
|
¥ 1699.9
|
期货,请咨询 |
阿拉丁 |
Astarabine
|
A671343-50mg
|
≥95% |
2098942-53-9 |
50mg
|
¥ 8999.9
|
期货,请咨询 |
阿拉丁 |
Astarabine
|
A671343-25mg
|
≥95% |
2098942-53-9 |
25mg
|
¥ 5999.9
|
期货,请咨询 |
阿拉丁 |
Ampreloxetine hydrochloride
|
A671194-5mg
|
≥95% |
1227056-87-2 |
5mg
|
¥ 2699.9
|
现货 |
阿拉丁 |
Ampreloxetine hydrochloride
|
A671194-25mg
|
≥95% |
1227056-87-2 |
25mg
|
¥ 8399.9
|
现货 |
阿拉丁 |
TIE-2/VEGFR-2 kinase-IN-2
|
A609020-50mg
|
Moligand™, ≥98% |
501693-48-7 |
50mg
|
¥ 8699.9
|
现货 |
阿拉丁 |
TIE-2/VEGFR-2 kinase-IN-2
|
A609020-1mg
|
Moligand™, ≥98% |
501693-48-7 |
1mg
|
¥ 729.9
|
现货 |
阿拉丁 |
TIE-2/VEGFR-2 kinase-IN-2
|
A609020-10mg
|
Moligand™, ≥98% |
501693-48-7 |
10mg
|
¥ 2699.9
|
现货 |
阿拉丁 |
AC263093
|
A607349-50mg
|
Moligand™, ≥98% |
849459-86-5 |
50mg
|
¥ 1399.9
|
现货 |
阿拉丁 |
AC263093
|
A607349-10mg
|
Moligand™, ≥98% |
849459-86-5 |
10mg
|
¥ 449.9
|
现货 |
阿拉丁 |
AC263093
|
A607349-100mg
|
Moligand™, ≥98% |
849459-86-5 |
100mg
|
¥ 2299.9
|
现货 |
阿拉丁 |
ABT-239
|
A607335-50mg
|
Moligand™, ≥98% |
460746-46-7 |
50mg
|
¥ 5299.9
|
现货 |
阿拉丁 |
ABT-239
|
A607335-10mg
|
Moligand™, ≥98% |
460746-46-7 |
10mg
|
¥ 1699.9
|
现货 |
阿拉丁 |
ABD-1970
|
A607324-50mg
|
Moligand™, ≥98% |
2010154-82-0 |
50mg
|
¥ 6249.9
|
期货,请咨询 |
阿拉丁 |
ABD-1970
|
A607324-10mg
|
Moligand™, ≥98% |
2010154-82-0 |
10mg
|
¥ 1953.9
|
期货,请咨询 |
阿拉丁 |
ABD-1970
|
A607324-100mg
|
Moligand™, ≥98% |
2010154-82-0 |
100mg
|
¥ 9999.9
|
期货,请咨询 |
阿拉丁 |
硅酸锆
|
Z736660-500g
|
≤1μm |
10101-52-7 |
500g
|
¥ 49.9
|
现货 |
阿拉丁 |
硅酸锆
|
Z736660-2.5kg
|
≤1μm |
10101-52-7 |
2.5kg
|
¥ 159.9
|
现货 |
阿拉丁 |
硅酸锆
|
Z736660-1kg
|
≤1μm |
10101-52-7 |
1kg
|
¥ 79.9
|
现货 |
阿拉丁 |
硅酸锆
|
Z736660-100g
|
≤1μm |
10101-52-7 |
100g
|
¥ 39.9
|
现货 |
阿拉丁 |
YM-53601
|
Y332775-5mg
|
≥98% |
182959-33-7 |
5mg
|
¥ 1959.9
|
现货 |
阿拉丁 |
YM-53601
|
Y332775-50mg
|
≥98% |
182959-33-7 |
50mg
|
¥ 9999.9
|
现货 |
阿拉丁 |
YM-53601
|
Y332775-25mg
|
≥98% |
182959-33-7 |
25mg
|
¥ 6249.9
|
现货 |
阿拉丁 |
YM-53601
|
Y332775-10mg
|
≥98% |
182959-33-7 |
10mg
|
¥ 3129.9
|
现货 |
阿拉丁 |